New Psychopharmacology :
Major Depression as an example
A Training Session for AsCNP, China September 12th 2013
藥理新进展訓練課
:
抑郁症
Professor SW Tang
University of California, Irvine, USA
Honorary Professor of Anatomy, University of Hong Kong Director , Institute of Brain Medicine
Q:
What is the purpose of life for
all life forms ?
Purpose of Life for all life forms :
(
生命之意義
)
“Eat well, then Reproduce”
“
不孝有三,無後為大”
Eating & Sex
Known for thousands of years:
a. “The desire for eating and sex is basic to animals, & is human nature” ; “When I was small, I adored my parents, Now I understand sex, I adore women”
(Mencius)
孟子 (告子):“人少则慕父母,知好色则慕少艾。”
告子曰:“食色性也”
b. “Eating and Sex are human wants” (Confucius)
Brain is NOT necessary
in the preservation of species originally
Intact
Emotional & Cognitive functions
are especially important for
Q:
which 2 chemicals play
important roles in emotional &
cognitive functions ?
Dopamine
DA
and Serotonin
5HT
are ancient and were present
in the primitive brain
Sub serving 2 fundamental purposes in Life
Sex, Eating and Reproduction
DA
5HT
5HT and DA evolved and bundled into
important pathways, extensively
innervating the higher brain to serve
complex functions in a complex society
Development and Refinement
in the roles of DA and 5HT to subserve the meaning of life have continued to evolve over the past
millions of years
The Human Brain has many more new roles in addition to sex and eating living in a complex 一
modern society
Reward and Pleasure have to be
5HT and DA pathways co-evolve
into two highly sophisticated
systems :
wiring for our complex feelings,
judgment and higher thinking
5HT
受體
21
4 5 6 7 B A F E D B C A 3 A Be.g. Many 5HT receptors
in higher life forms in a complex society serving different purposes
Genetic or other Pathological changes in these two neurotransmitters (or their
functions/pathways) therefore may have grave consequences , manifested in symptoms of
“altered experience in Reward & Pleasure ” e.g. anhedonia, apathy, inappropriate or
disproportionate emotional and cognitive responses to stimuli
Q:
What do antidepressants do ?
Major Depression is not unhappiness
Sustained impairment (almost every day) > 2 weeks
Not only depressed mood > 5 symptoms ( significant impairment in social, work, or other important areas of functioning
1. Depressed mood most of the day
2. Diminished interest or pleasure in all or most activities 3. Significant unintentional weight loss or gain
4. Insomnia or sleeping too much
5. Agitation or psychomotor retardation noticed by others 6. Fatigue or loss of energy
7. Feelings of worthlessness or excessive guilt
8. Diminished ability to think or concentrate, or indecisiveness 9. Recurrent thoughts of death
Q:
Comment on the
pharmacology & neuroanatomy
of happiness and depression
Unhappiness
(a mood state)
or an unhappy character
is often mistaken
as the mood disorder (an illness)
** Very important concept
Drugs for treating depression are not drugs inducing happiness
Happiness and Major Depression
Recent Clinical Neuroscience research showed
Neuroanatomical and Neurochemical substrates for “unhappiness” and for “Major Depression ” may have evolved together but distinguished
themselves for different purposes over evolution These new data may help us to understand the
differential effects of drug & non-drug treatment in reversing major depression and in creating
happiness and also many long standing confusion in treatment targets and treatment end points
Drugs inducing pleasure may not be
true antidepressants ?
Pleasure and Mood may involve separate neuropathways/circuits ?
Major Depression is NOT unhappiness
But inducing pleasure/optimism may mask depression symptoms or give temporary relief in short term ( ? Apparent and transient effects of certain talk, music,
aromatic therapies and basis of various addiction in patients)
Compounds and other procedures
with fast mood actions
Drug of abuse (e.g cocaine…)
Ketamine, sleep deprivation, brain stimulation ……….
NA
VTA
ACC
快感的神經線路
NA
PFC
VTA
ACC
Neuro- Circuit for Pleasure/Reward
Addiction
DBS A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression . Lozano et al., J Neurosurg. 2012;
Deep brain electro-stimulation
Rat
Depressed patients
NeuroCircuits in Major Depression Frontal Cognitive Input Dorsal Raphe Amygdala Hippocampus Stress Inflammatory -ve Antidepressants + ve
Some Important
Hypothesis/Theories of Major
Depression
&
Q: WHICH PART(S) OF OUR
BRAIN MAKE US HUMAN ?
The PreFrontal Lobes
MPFC OFC RFC ACC LPFC DLPFC VLPFCThe New Man’s Pre-Frontal Cortex
A brain lacking the human brain (frontal) to control the animal (limbic) brain
or
A brain with pathological animalistic brain parts
Amygdala Weak Frontal Cortex 修養 Over-active Animalistic drives : Impulsive Strong Frontal Cortex Controlled limbic Un-buffered emotions Solution direct, e.g. physical Highly Buffered Calculated Solution Strategies Strong Limbic
Dogs could be trained to delay gratification before certain age
Animal Brain Limbic Human Br ai n Fr o n tal cort ex 我們的野獸冲動受制于前腦 Emotions : Happiness, Anger, Rage, Sadness, Lust, Bonding, Love, Trust, …..
Higher Thinking: Wisdom, Humor Strategy, delay gratification
ACC
vmPFC Amygdala
Hippocampus
前腦調節情緒的機制
Brain parts identified for emotions and the controls
Hypofrontality
Early childhood development
Resilience Training (修養, 毅力) Psychotherapy ,Talk Therapies Drugs
2. Amine Hypothesis :
Functional Impairment of
Aminergic Neuro-transmission
Increase functional Amines : e.g. Amine Reuptake Blockers
3. MAOI (A & B) 2. Auto-receptor Antagonist 1. Re-uptake Inhibitors all TCAs, SSRIs, SNRIs NRIs,NDRI
Current Antidepressant Drug
Targets Examples: 1. Amitriptyline, Imipramine Fluoxetine (Prozac) Paroxetine (Paxil) Escitalopram (Lexapro) Venlafaxine and metabolites Duloxetine, Bupropion 4. 5HT2C 2.Mirtarzapine,Mianseri n 3. Pargyline, Phenelzine (Nardil) Selegiline (Deprenyl) Tranylcypromine (Parnate) Rasageline 4. Other compounds on 5HT receptors (e.g. 5HT2c) Agomelatine (antagonist) , trazodone (agonist)
Clinical reality
Irrespective of Dx
Categories Drugs
Current antidepressant treatable Current antidepressant compounds Augmentation needed Add Lithium, or other antidepressant (
e.g. escitalopram + mirtazapine), or antipsychotics (e.g. aripiprazole,
resiperidone), or thyroxin, estrogen, ……… Incomplete responses Polypharmacy, any new drug, ??????? Resistant cases Polypharmacy, any new drug, ??????? Unclear diagnosis Antidepressants , polypharmacy, & any
psychotropic drugs plus other compounds ? ??????
Reality in Clinic :
Recycling or Polypharmacy
TCAs, SSRIs, SNRIs, NDRIs, 5HT2c agents, Li, MAOIs,……
Ocean of compounds with antidepressant property or compounds with augmentation property
Q:
Have we reached the limit in
the development of DA/5HT
antidepressant drugs ?
or Have we fully exploited the Amine
Hypothesis of Depression in the development of antidepressant drugs ?
3. Depression as
a neuro-toxic disease
Hypothesis
3 a
.
Cortisol Toxicity Model
Stress (sustained & serious) Cortisol BDNF
suppression Impairment/Damage of
spines/dendrtites/neruons Depressive
symptoms
Antidepressant Treatment BDNF gene
expression elevated BDNF
spinogenesis/dendritogenesis/neurogenesis
Reversal of depression state
Q:
Do antidepressant drugs work
through producing new neurons
Enhance Neurogenesis
Dendritogenesis & Synaptogenesis
Dendrtie with spines and synapses
3 b. Mitochondria Dysfunction
and Oxidative damage
Inflammatory
Neurodegenerative Hypothesis
Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders.
Gardner and Boles 2011, Prog Neuropsychopharmacol Biol Psychiatry 2011
Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder
Neuro-degeneration
Spine loss
Dendritic shortening and loss
Reduced neuronal & glial numbers
Reduced packing density and size of neurons Loss of prefrontal inhibitory circuits
Decrease pyramidal neuron soma size
All reduced hippocampal & other brain area volume
Campbell 2004; Campbell and MacQueen 2006; Parashos et al., 1998; stockmeier et al., 2004; Steingard et al., 2002; Vasic et al., 2008; Zou et al., 2010
Mitochondria Pathology Model
A. Chronic Stress
1.Chronic cortisol elevation chronic increases in mitochondria activity & oxidative, Ca++
activities impaired mitochondria function & mitochondrial DNA damages
2. Pro-inflammatory cytokines impaired
mitochondrial functions
B. Mitochondrial defects from other causes C. Genetic mitochondrial defects
Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Gardner and Boles 2011, Prog Neuropsychopharmacol Biol Psychiatry 2011 Impaired mitochondrial function in psychiatric disorders . Manji et al., Nature Reviews Neuroscience 2012
Q :
Why are there significant %
of depression cases not
responsive to antidepressant
treatment?
University based clinicians and
researchers emphasized the
importance of accurately diagnosing
“Depression” for good reasons
In reality, Depressions : A mixed bag
Cases Not fulfilling
DSM Diagnostic criteria Mixed features;
Unhappiness May or
May not respond to antidepressants
DSM but
Resistant cases
DSM & Rx
responsive cases
Q:
Only those fulfilling the DSM/ICD
Diagnostic criteria should go on
antidepressants?
or, Depression is only a symptom of a
variety of CNS/Mood/Cognitive
The Rippling Effects of
a Brain Disorder
Tertiary Consequences Secondary Disturbances Primary PathologyThe
Clinical Reality
after Initiation of
Rx
Current Antidepressant treatable
Augmentation needed
Incomplete response cases
However, Current Antidepressant drugs induced remission in a significant % of
depressed cases
Common Scenario
:1
stdrug
~ 30-60 % patient responded
2nd drug~ 10 % patient of the remaining responded 3rd drug
~ 2- 5 % of remaining responded
Adding another drug to existing : ~ 5 -10 %
Though Resilience factor remains a difficult and significant problem when facing adversity
Or, perhaps after all, Depression
is only a symptom of a variety of